Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma

Originating in the brain, glioblastoma (GBM) is a highly lethal and virtually incurable cancer, in large part because it readily develops resistance to treatments. While numerous studies have investigated mechanisms enabling GBM cells to evade chemotherapy-induced apoptosis, few have addressed how t...

Full description

Saved in:
Bibliographic Details
Published in:Matrix biology 2020-01, Vol.85-86, p.128-146
Main Authors: Xiao, Weikun, Wang, Shanshan, Zhang, Rongyu, Sohrabi, Alireza, Yu, Qi, Liu, Sihan, Ehsanipour, Arshia, Liang, Jesse, Bierman, Rebecca D., Nathanson, David A., Seidlits, Stephanie K.
Format: Article
Language:English
Subjects:
3D culture
Apoptosis
Arginine
Aspartic acid
BCL-2 family
Bcl-2 protein
Biomaterials
Brain cancer
Brain Neoplasms - drug therapy
Brain Neoplasms - metabolism
Brain tumors
CD44
CD44 antigen
Cell culture
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chemoresistance
Chemotherapy
Cilengitide
Dasatinib
Drug resistance
Drug Resistance, Neoplasm
Extracellular matrix
Extracellular Matrix - metabolism
Gene Expression Regulation, Neoplastic - drug effects
Glioblastoma
Glioblastoma - drug therapy
Glioblastoma - metabolism
Glycine
Humans
Hyaluronan Receptors - metabolism
Hyaluronic acid
Hyaluronic Acid - chemistry
Hyaluronic Acid - pharmacology
Integrin
Integrin alphaV - metabolism
Models, Biological
Oligopeptides - chemistry
Oligopeptides - pharmacology
Src
Temozolomide
Temozolomide - pharmacology
Tissue Scaffolds - chemistry
Tumor Microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Originating in the brain, glioblastoma (GBM) is a highly lethal and virtually incurable cancer, in large part because it readily develops resistance to treatments. While numerous studies have investigated mechanisms enabling GBM cells to evade chemotherapy-induced apoptosis, few have addressed how their surrounding extracellular matrix (ECM) acts to promote their survival. Here, we employed a biomaterial-based, 3D culture platform to investigate systematically how interactions between patient-derived GBM cells and the brain ECM promote resistance to alkylating chemotherapies — including temozolomide, which is used routinely in clinical practice. Scaffolds for 3D culture were fabricated from hyaluronic acid (HA) — a major structural and bioactive component of the brain ECM — and functionalized with the RGD (arginine-glycine-aspartic acid) tripeptide to provide sites for integrin engagement. Data demonstrate that cooperative engagement of CD44, through HA, and integrin αV, through RGD, facilitates resistance to alkylating chemotherapies through co-activation of Src, which inhibited downstream expression of BCL-2 family pro-apoptotic factors. In sum, a bioengineered, 3D culture platform was used to gain new mechanistic insights into how ECM in the brain tumor microenvironment promotes resistance to chemotherapy and suggests potential avenues for the development of novel, matrix-targeted combination therapies designed to suppress chemotherapy resistance in GBM. [Display omitted] •Hyaluronic acid (HA) and RGD-containing proteins in the extracellular matrix (ECM) protect glioblastoma (GBM) from apoptosis.•Interactions between CD44 and HA and integrin aV and RGD increase Src activation.•Matrix-mediated Src activation promotes invasive morphologies and deregulates pro-apoptotic factors induced by chemotherapy.•Chemotherapy combined with Src inhibition provides a strategy to overcome matrix-mediated resistance in GBM.
ISSN:0945-053X
1569-1802
DOI:10.1016/j.matbio.2019.04.003